Thus, TdT is regarded as a marker of precursor B cells and their derived leukaemias and lymphomas, i.e. B‐lymphoblastic leukaemias/lymphomas (B‐ALLs/LBLs). The gene discussed is DNTT; the disease is lymphoma.